The approval was given after its clinical trials on Covid-19 patients in India was found satisfactory by the expert committee
from Latest News https://ift.tt/2ZiH05R
Friday, 10 July 2020
Drug regulator okays limited use of Itolizumab for Covid-19 patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment